Motley Fool

Why Shares of Ocugen Climbed Today

Shares of biotech company Ocugen (NASDAQ: OCGN) jumped nearly 13% today as the latest COVID figures show a significant rise in cases, hospitalizations, and deaths — especially among the unvaccinated. Over the last two weeks, COVID cases are up 140%, while hospitalizations and deaths are up by one-third. Ocugen has partnered with Bharat Biotech, the company responsible for Covaxin, the first COVID vaccine developed in India to receive emergency authorization.

LEAVE A REPLY

Please enter your comment!
Please enter your name here